Junxia Gu
- Topics
- Osteoarthritis Treatment and Mechanisms (7 papers)Bone Metabolism and Diseases (6 papers)Cancer-related Molecular Pathways (5 papers)
- Partner nations
- ChinaUnited StatesUnited Arab Emirates
In The Last Decade
Junxia Gu
35 papers receiving 391 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 251
- Cancer Research 99
- Oncology 74
- Rheumatology 50
- Pulmonary and Respiratory Medicine 35
Countries citing papers authored by Junxia Gu
This map shows the geographic impact of Junxia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxia Gu more than expected).
Fields of papers citing papers by Junxia Gu
This network shows the impact of papers produced by Junxia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxia Gu. The network helps show where Junxia Gu may publish in the future.
Co-authorship network of co-authors of Junxia Gu
This figure shows the co-authorship network connecting the top 25 collaborators of Junxia Gu. A scholar is included among the top collaborators of Junxia Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxia Gu. Junxia Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | CircCRIM1 suppresses osteosarcoma progression via sponging miR146a-5p and targeting NUMB. | 3 |
| 3 | Silence of URI in gastric cancer cells promotes cisplatin-induced DNA damage and apoptosis. | 6 |
| 4 | CircNRIP1 acts as a sponge of miR-1200 to suppress osteosarcoma progression via upregulation of MIA2. | 3 |
| 5 | 10 | |
| 6 | 21 | |
| 7 | T-box family of transcription factor-TBX5, insights in development and disease. | 16 |
| 8 | 13 | |
| 9 | URI promotes the migration and invasion of human cervical cancer cells potentially via upregulation of vimentin expression. | 7 |
| 10 | URI prevents potassium dichromate-induced oxidative stress and cell death in gastric cancer cells. | 15 |
| 11 | 35 | |
| 12 | Endothelin-A receptor antagonists in prostate cancer treatment-a meta-analysis. | 18 |
| 13 | Mammalian target of rapamycin (mTOR) inhibitors and combined chemotherapy in breast cancer: a meta-analysis of randomized controlled trials. | 9 |
| 14 | 10 | |
| 15 | Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis. | 12 |
| 16 | Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry. | 22 |
| 17 | 28 | |
| 18 | 12 | |
| 19 | [Effects of acute myeloid leukemia cell supernatant on the proliferation and apoptosis of CD4+ and CD8+ T cell subsets]. | 1 |
| 20 | [Effect of curcumin on STAT5 signaling pathway in primary CML cells]. | 9 |
About Junxia Gu
Junxia Gu is a scholar working on Cancer Research, Rheumatology and Oncology, having authored 35 papers that have together received 392 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Bone Metabolism and Diseases (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (99 citations), Molecular Biology (251 citations) and Rheumatology (50 citations). Junxia Gu has collaborated with scholars based in China, United States and United Arab Emirates. Frequent co-authors include Qiping Zheng, Yaojuan Lu, Longwei Qiao, Yuting Liang, Xiaoxia Hu, Biaohua Chen, Na Li, Xingang Li, Qian Wang and Jingcheng Miao. Their work appears in journals such as Journal of Biological Chemistry, Gene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.